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most European countries and were the rationale 
for establishing the European Association of Per­
cutaneous Cardiovascular Interventions (EAPCI) 
Women Committee. One of the aims of the EAPCI 
is to identify the determinants of these striking 
sex disparities in the transition from the medical 
school to IC and to develop strategies for equal 
career opportunities in the field of IC.4
According to an EAPCI Women Committee 
survey, several barriers preclude women from 
IntroductIon Statistics are extremely unfa­
vorable for female interventional cardiologists in 
Poland. Women represent less than 5% of board­
­certified interventional cardiologists. Although 
women constitute 43% of all cardiologists, only 
1% of them work in the field of interventional car­
diology (IC).1,2 This small number of female inter­
ventional cardiologists contradicts the fact that 
most medical students are female (75%).3 These 

















Background A small number of female cardiologists work in the field of interventional cardiology. Such 
disparity is observed in most European countries.
aims We present the first national report on the practice patterns and outcomes regarding percutaneous 
coronary interventions (PCIs) performed by female operators (FOs) in Poland.
methods Data were collected from the National Registry of Invasive Cardiology Procedures (Ogólnopolski 
Rejestr Procedur Kardiologii Inwazyjnej [ORPKI]) between January 2014 and December 2017.
results A total of 31 FOs (4.1%) performed 12 935 PCIs (2.8%). The median (interquartile range [IQR]) 
number of PCIs performed by FOs per year was 75 (43–154), whereas that by male operators was 139 (67–216; 
P <0.01). Patients handled by FOs were characterized by a lower prevalence of cardiovascular risk factors and 
previous coronary artery interventions. Acute coronary syndrome was the main indication for treatment 
(74.66%). Compared with male operators, FOs handled significantly more patients with single ‑vessel disease 
(87.02% vs 84.72%; P <0.001). There was no difference in clinical outcomes (a composite of all ‑cause death, 
bleeding at the puncture site, or coronary artery perforation) associated with the operator’s sex.
conclusions Women represent a minority of operators in interventional cardiology and are responsible 
for a low percentage of PCIs. Nonetheless, the practice patterns and outcomes of PCIs performed by FOs 
are similar to those of male operators.
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the Kolmogorov–Smirnov and Lilliefors tests. 
The t test or the Wilcoxon rank sum test were 
used to compare continuous variables across the 
2 study groups. Nominal variables were present­
ed as numbers and percentages, and then com­
pared using the Pearson χ2 test or the Fisher ex­
act test, as appropriate. The Cochran–Armitage 
test for trend was used to examine changes over 
the analyzed years. Pearson or Spearman cor­
relation coefficients were calculated as appro­
priate. To account for potential selection bias 
in the comparison of female and male opera­
tors, propensity score matching (PSM) was per­
formed using the nearest ­neighbor method with 
the following covariates: age, sex, weight, diabe­
tes, previous stroke, previous myocardial infarc­
tion, previous PCI, previous coronary artery by­
pass grafting, smoking status, psoriasis, hyper­
tension, kidney disease, indication, Killip class, 
chronic obstructive pulmonary disease, access 
site, cardiac arrest at baseline, and hypother­
mia at baseline. The groups were considered bal­
anced if the standardized difference for each of 
the analyzed baseline or demographic character­
istics was lower than 10%. Thrombolysis, the use 
of glycoprotein IIb / IIIa inhibitors, bivalirudin, 
fractional flow reserve (FFR), intravascular ul­
trasound (IVUS), optical coherence tomogra­
phy (OCT), total radiation dose, total contrast 
agent dose, aspirin, unfractionated heparins, 
low ­molecular ­weight heparins, and complica­
tions (bleeding at the puncture site, cardiac ar­
rest, allergic reaction, and death) were regard­
ed as dependent variables in mixed effect mod­
els, with each outcome having a separate model. 
The operator’s sex was used as a fixed effect; ran­
dom effects were used to account for data clus­
tering. A P value less than 0.05 was considered 
significant. Statistical analysis was performed 
with the R­3.6.2 software (R Foundation for Sta­
tistical Computing, Vienna, Austria).
results During our study period, 163 Polish 
catheterization laboratories reported PCI pro­
cedures into the ORPKI registry. Of these, only 
59 (36%) had at least a single female operator 
(FO) and 19 (11%) employed more than one FO 
(range, 2–5). The ORPKI registry indicated a to­
tal of 867 interventional operators performing 
diagnostic procedures (46 women [5.3%] vs 821 
men [94.7%]) and 757 operators performing di­
agnostic and therapeutic procedures (31 women 
[4.1%] vs 726 men [95.9%]) over 4 years. The an­
nual trend of the number of FOs performing 
therapeutic procedures was as follows: 23 (3.6%) 
in 2014; 25 (3.7%) in 2015; 29 (4.1%) in 2016; 
30 (4.5%) in 2017 (P = 0.44).
A total of 1 272 396 consecutive procedures 
(447 390 angiography only, 368 551 angiogra­
phy followed by PCI, and 456 455 PCI only) were 
included in the analysis. Of the total reported 
choosing IC, including lack of opportunity, 
concerns regarding radiation exposure, and 
perceived prejudices from male colleagues in 
the workplace.5 Passion is the most common 
reason for choosing IC. According to male inter­
ventional cardiologists responding to the same 
survey, their most frequently perceived reasons 
for women not choosing career in IC include on­
­calls and long working hours in catheterization 
laboratories.5
In contrast, there have been limited data re­
garding the practice patterns, procedural vol­
umes, and outcomes of percutaneous coronary 
procedures performed by female interventional­
ists. Whether the operator’s sex impacts the pat­
tern of percutaneous IC procedures remains un­
known. Thus, we present the first national re­
port on the practice patterns and outcomes of 
IC procedures performed by female interven­
tionalists in Poland.
Methods The National Registry of Invasive 
Cardiology Procedures (Ogólnopolski Rejestr 
Procedur Kardiologii Inwazyjnej [ORPKI]) is 
a nationwide registry of all percutaneous IC pro­
cedures performed in Poland. Medical data used 
in this study were collected from all invasive car­
diology sites (catheterization laboratories) be­
tween January 2014 and December 2017. Prop­
erly anonymized clinical and angiographic char­
acteristics of all IC procedures are electronical­
ly submitted to 3 ORPKI modules: angiography 
only, angiography followed by PCI, and PCI only. 
Patient informed consent is obtained at the time 
of original data collection. The registry analysis 
in this study did not require any ethical approv­
al. Detailed data on the ORPKI registry design 
have been presented elsewhere.6
statistical analysis Continuous variables 
were expressed as mean (SD) or median (in­
terquartile range [IQR]) for normally or non­
­normally distributed variables, respectively. 
The normality of distribution was assessed using 
whAt’s new?
Only 1% of female cardiologists work in the field of interventional cardiology. 
This disparity is observed in most European countries. Percutaneous coronary 
interventions (PCIs) performed by female interventionalists account for less 
than 3% of the overall PCI volume in Poland. Female operators (FOs) mostly 
handle patients with a low prevalence of cardiovascular risk factors. Most FOs 
are low ‑volume operators, whereas male operators perform almost double 
the number of PCIs annually compared with FOs. Nonetheless, our study 
showed that there was no difference in clinical outcomes, associated with the 
operator’s sex. The practice patterns and outcomes of PCIs performed by FOs 
are similar to those of male operators. A large multicenter analysis is needed 
to further investigate the impact of the operator’s sex on clinical outcomes in 
interventional cardiology. Therefore, more FOs should be involved in 
interventional cardiac procedures.
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vs 1.35%; P <0.001). The PSM analysis demon­
strated that the odds of FFR use during diagnos­
tic angiography by FOs were significantly low­
er compared with MOs (odds ratio [OR], 0.47; 
95% CI, 0.4–0.55; P <0.001). However, the num­
ber of physiological assessments during diagnos­
tic angiography performed by FOs increased an­
nually from 74 (0.94%) in 2014 to 126 (1.69%) 
in 2017 (P <0.001). The use of invasive imaging 
techniques among operators during diagnos­
tic coronary angiography confirmed that OCT 
was preferred by FOs (0.42% vs 0.08%; P <0.001) 
compared with IVUS (0.39% vs 0.5%; P <0.001), 
which was more often performed by MOs.
The access site during angiography did not 
differ between operators’ sexes. During the an­
alyzed years, radial access increased from 62% of 
cases to 80% (P <0.001). The proportion of radi­
al access use increased with growing operators’ 
experience (r = 0.38, P <0.05; r = −0.37, P <0.05).
A total of 31 female interventionalists (4.1%) 
performed 12 935 PCIs (2.8%) during the 4 an­
alyzed years. Acute coronary syndrome was 
the main indication for treatment (74.66%) 
(TABLe 2). Compared with MOs, FOs performed 
a larger proportion of procedures in patients 
with ST ­segment elevation myocardial infarc­
tion (27.43% vs 24.48%; P <0.001). Patients 
handled by FOs were characterized by a lower 
prevalence of cardiovascular risk factors and 
previous coronary artery interventions (PCI or 
procedural volume during the analyzed period, 
FOs performed 29 721 diagnostic coronary pro­
cedures (3.6%) and 12 935 percutaneous coro­
nary therapeutic procedures (2.8%) (TABLeS 1 and 2). 
Female and male operators performed a median 
(IQR) number of 495 (147–994) and 853 (396–
1361) (P <0.01) diagnostic coronary angiogra­
phies, respectively, and 305 (186–619) and 562 
(283–869) (P = 0.01) PCIs, respectively. The me­
dian (IQR) number of PCIs performed by FOs 
per year was 75 (43–154), which was significant­
ly lower than the median number of procedures 
performed by male operators (MOs) (139 [67–
216]; P <0.01).
A subanalysis of the data on diagnostic coro­
nary artery procedures is presented in TABLe 1 and 
Supplementary material, Table S1. Stable angina 
pectoris was the main indication for angiography 
for all operators, but it was a more frequent indi­
cation for FOs than for MOs (43.89% vs 38.33%; 
P <0.001). No evidence of atherosclerosis during 
diagnostic angiography was more often diag­
nosed in the patient population handled by FOs 
(14.83% vs 9.95%; P <0.001). However, the pres­
ence of left main coronary artery disease or mul­
tivessel disease detected by diagnostic angiogra­
phy was positively correlated with the number 
of PCIs performed by women (r = 0.54, P <0.001 
and r = 0.52, P <0.001, respectively).
The physiological assessment during angiog­
raphy was more frequently used by MOs (2.24% 
Table 1 Diagnostic coronary angiography characteristics based on data from the ORPKI registry collected 
between January 2014 and December 2017







Coronary angiography 815 941 (100) 29 721 (3.64) 786 220 (96.36) <0.001
Indication for angiography
STEMI 94 794 (11.62) 3224 (10.85) 91 570 (11.65) <0.001
NSTEMI 105 212 (12.89) 3213 (10.81) 101 999 (12.97)
UA 258 335 (31.66) 8163 (27.47) 250 172 (31.82)
SA 314 367 (38.53) 13 044 (43.89) 301 323 (38.33)
Other 43 233 (5.3) 2077 (6.98) 41 156 (2.5)
Results of angiography
No evidence of 
atherosclerosis
82 559 (10.13) 4405 (14.83) 78 154 (9.95) <0.001
No significant stenosis 210 845 (25.87) 7116 (23.96) 203 729 (25.94)
Single ‑vessel disease 211 920 (26) 7176 (24.17) 204 744 (26.07)
LMCA disease 2644 (0.32) 103 (0.35) 2541 (0.32)
Multivessel disease 248 975 (30.55) 8871 (29.87) 240 104 (30.58)
Multivessel and LMCA disease 58 047 (7.12) 2024 (6.82) 56 023 (7.13)
Data are presented as number (percentage) of procedures.
Abbreviations: LMCA, left main coronary artery; NSTEMI, non–ST ‑segment elevation myocardial infarction; SA, stable angina; 
STEMI, ST ‑segment elevation myocardial infarction; UA, unstable angina
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With the increase in female operators’ experi­
ence, a slight upward trend was observed in their 
treatment of complex lesions (r = 0.37, P <0.05).
In the context of treatment, drug ­eluting 
stents were widely used by all operators (82.63%), 
but MOs more often used multiple stents dur­
ing single procedures than FOs did (15.72% vs 
14.42%; P <0.001) (Supplementary material, 
Table S2). Nevertheless, an increase in the num­
ber of stents used per procedure was observed in 
coronary artery bypass graft surgery) (Supple­
mentary material, Table S2). Moreover, FOs per­
formed significantly more procedures in patients 
with single ­vessel disease (87.02% vs 84.72%; 
P <0.001) except the left main vessel (2.26% vs 
3.21%; P <0.001) or bypass graft (0.94% vs 1.28%, 
P <0.001). Multivessel disease or complex lesions, 
such as chronic total occlusion, calcified lesions, 
and bifurcation lesions, were more frequent­
ly observed in patients handled by MOs (TABLe 2). 
Table 2 Percutaneous coronary interventions based on data from the ORPKI registry collected between 
January 2014 and December 2017
Parameters All operators 
(n = 757)
Female operators 
(n [%] = 31 [4.1])
Male operators 
(n [%] = 726 [95.9])
P value
Procedures (PCI) 456 455 (100) 12 935 (2.8) 443 520 (97.2) <0.001
Indication
ACS 451 629 (72.18) 9562 (74.66) 319 956 (72.91) <0.001
STEMI 111 782 (24.48) 3548 (27.43) 108 234 (24.4)
NSTEMI 87 433 (19.15) 2411 (18.64) 85 022 (19.17)
UA 130 303 (28.55) 3603 (27.85) 126 700 (28.57)
SA 122 111 (26.75) 3245 (25.09) 118 866 (26.8)
Other 4826 (1.06) 128 (0.99) 4698 (1.06)
PCI treatment based on lesion data
Single ‑vessel disease 387 245 (84.79) 11 256 (87.02) 375 989 (84.72) <0.001
LMCA disease 6082 (1.33) 130 (1.01) 5952 (1.34)
Multivessel disease 39 973 (8.75) 955 (7.38) 39 018 (8.79)
Multivessel and LMCA disease 8476 (1.86) 162 (1.25) 8314 (1.87)
Other procedures 14 956 (3.27) 432 (3.34) 14 524 (3.27)
CTO 10 635 (2.33) 180 (1.39) 10 455 (2.36)
Bifurcation 21 010 (4.60) 378 (2.92) 20 632 (4.65)
Rotablation 2159 (0.47) 12 (0.09) 2147 (0.48)
Implanted stent 405 307 (88.74) 11 505 (88.94) 393 802 (88.73) 0.46
Stent type
BMS 20 218 (4.43) 788 (6.09) 19 430 (4.38) <0.001
DES 377 392 (82.63) 10 520 (81.33) 366 872 (82.67)
BVS 4397 (0.96) 80 (0.62) 4317 (0.97)
Mixed type (BMS, BVS, DES) 2553 (0.56) 102 (0.79) 2451 (0.56)
No stent used 51 425 (11.26) 1430 (11.06) 49 995 (11.27)
≥2 stents 71 621 (15.68) 1865 (14.42) 69 756 (15.72)
DEB 16 147 (3.54) 472 (3.65) 15 675 (3.54) 0.48
Periprocedural complications during PCI
Coronary artery perforation 782 (0.17) 22 (0.17) 760 (0.17) 0.97
Bleeding at the puncture site 449 (0.1) 8 (0.06) 441 (0.1) 0.18
Death during procedure 2101 (0.46) 74 (0.57) 2027 (0.46) 0.06
Data are presented as number (percentage) of procedures.
Abbreviations: ACS, acute coronary syndrome; BMS, bare metal stent; BVS, bioresorbable scaffold; CTO, chronic total occlusion; DEB, drug­
‑eluting balloon; DES, drug ‑eluting stent; LMCA, left main coronary artery; PCI, percutaneous coronary intervention; others, see TABLe 1
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for less than 3% of the overall PCI volume in 
Poland. Similar results were presented by Wang 
et al,8 based on data from the United States Na­
tional Cardiovascular Data Registry. Further­
more, our analysis showed that 3.6% of all di­
agnostic coronary procedures were performed 
by FOs, but 2.8% were elective PCIs; this con­
firms the fact that women are assigned to less 
demanding procedures in advance. Insufficient 
procedural experience may explain the gap be­
tween the diagnostic and therapeutic procedure 
involvement of FOs. In a study by Wang et al,8 
most FOs were found to be low ­volume opera­
tors compared with MOs. Nonetheless, Polish 
FOs are higher ­volume operators compared with 
FOs in the United States; the median (IQR) num­
ber of PCIs performed annually by FOs in Po­
land is 75 (43–154), as opposed to 48 (22–87) in 
the United States.8 As recommended by the Asso­
ciation of Cardiovascular Intervention of the Pol­
ish Cardiac Society, each operator should per­
form a minimum number of 75 PCI procedures 
annually. Therefore, FOs barely reach this min­
imum, whereas MOs perform almost double 
the number every year.
Previous studies have demonstrated that low­
­volume operators more often perform emer­
gency PCIs compared with high ­volume opera­
tors, and the patients of the former have few­
er cardiovascular comorbidities8,10; this trend is 
in line with our observations. Low ­volume FOs 
are less likely to be given an opportunity to treat 
more complex lesions such as chronic total oc­
clusion and left main coronary artery or calcif­
ic lesions. Therefore, in routine practice, case se­
lection for FOs is mainly focused on stable pa­
tients with a lower prevalence of cardiovascular 
risk factors. We further observed in our analy­
sis that an increase in FOs’ experience contrib­
uted to only a slight upward trend in complex 
lesion treatment by women. Thus, additional 
factors may influence the spectrum of patients 
treated by FOs.
The use of the physiological assessment (FFR) 
or additional imaging techniques (IVUS and 
OCT) is highly recommended by the European 
Society of Cardiology guidelines on myocardial 
revascularization.10 Our study confirmed that 
both groups of operators do not widely use OCT, 
IVUS, or FFR in routine practice, but an upward 
trend can be noticed during the analyzed years. 
However, the significantly higher probability 
of conducting the OCT assessment by FOs dur­
ing diagnostic procedures should be interpret­
ed with caution due to the small overall num­
ber of performed procedures. Furthermore, low­
­volume operators are more likely to use an ad­
ditional physiological and imaging assessment 
during diagnostic procedures. Based on recom­
mendations, FFR ­guided PCI is performed in pa­
tients with multivessel disease or left main le­
sions; these indications predominated for MOs 
the group of experienced FOs (r = 0.5, P <0.01). 
As shown by the PSM analysis, low ­molecular­
­weight heparins were less commonly used 
by FOs compared with MOs (OR, 0.6; 95% CI, 
0.44–0.8; P <0.001), but opposite results were 
noted for unfractionated heparins (OR, 1.19; 95% 
CI, 1.11–1.28; P <0.001), and the probability of us­
ing glycoprotein IIb / IIIa inhibitors during PCI 
was significantly higher for FOs than for MOs 
(OR, 2.34; 95% CI, 1.59–3.51; P <0.001). In addi­
tion, a moderate correlation could be observed 
for the use of glycoprotein IIb / IIIa inhibitors by 
high ­volume FOs compared with MOs (r = 0.54, 
P <0.01 and r = 0.6, P <0.001, respectively).
Additional imaging techniques (main­
ly IVUS ­guided PCI) were more often used by 
MOs (0.81% vs 0.32%; P <0.001) (Supplementa­
ry material, Table S2). However, the PSM anal­
ysis did not confirm any statistical significance 
of IVUS ­guided PCIs performed by MOs (OR, 
0.574; 95% CI, 0.32–1.001; P = 0.054).
The PSM analysis confirmed that the total 
radiation dose used by MOs was significantly 
lower (by 54.8 mGy) during PCI (P <0.001). Fur­
thermore, we observed a significant reduction in 
the amount of contrast agent (mean [SD], from 
175 [81] cm3 to 167 [78] cm3; P <0.001) and radi­
ation (median [IQR], from 1013 [502–1779] mGy 
to 767 [453–1221] mGy; P <0.001) by FOs over 
the analyzed years.
Regarding patient outcomes (a composite of 
all ­cause death, bleeding at the puncture site, 
or coronary artery perforation) following diag­
nostic and therapeutic procedures, there was no 
difference caused by the operator’s sex (TABLe 2).
dIscussIon The ORPKI registry provides 
a unique insight into the contemporary PCI 
practice patterns in Poland. The national scope 
and comprehensive data allowed us to compare 
the procedural characteristics and outcomes as­
sociated with interventionalists’ sex.
Data from the ORPKI registry confirmed the 
staggering disproportion of practicing female 
interventionalists compared with MOs in Po­
land. This trend has been observed in numer­
ous countries. In France, women constitute only 
3% of interventional cardiologists7; in the Unit­
ed States, only 4.5% of board ­certified interven­
tional cardiologists8; in Australia and New Zea­
land, only 4.8% of physicians performing in­
terventional procedures.9 In Poland, there has 
been an upward trend (an increase of 0.9 per­
centage points) in the number of FOs in recent 
years. However, it has not changed significantly, 
and this number remains low. As a result, FOs 
work in a highly male ­dominated environment 
and lack mentorship from female peers within 
the same catheterization laboratories.
Percutaneous coronary interventions per­
formed by female interventionalists account 
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in our analysis. In general, the choice of treat­
ment and the combination of additional physi­
ological or imaging assessment techniques de­
pend on each patient’s characteristics, comor­
bidities, and clinical settings. Therefore, the low­
er involvement of FOs in the treatment of com­
plex lesions and patients with a higher incidence 
of comorbidities may be responsible for the de­
scribed discrepancies in patient management.
Finally, the current literature provides contra­
dictory data regarding the relationship of the op­
erator volume with post ­PCI outcomes. Some 
studies have demonstrated that high ­volume 
operators have a significantly lower rate of in­
­hospital deaths than low ­volume operators (OR, 
0.79; 95% CI, 0.75–0.83).11 In contrast, the last 
published data from the ORPKI registry showed 
that there was no significant correlation between 
operator volume and the procedure ­related mor­
tality rate in the overall group of patients under­
going PCI.12 Our analysis is consistent with these 
results; procedure ­related mortality did not sig­
nificantly differ between high ­volume male and 
low ­volume female operators.
The increasing proportion of women perform­
ing medical professions is a worldwide observa­
tion. Hopefully, the presented clinical data and 
initiatives such as those of the EAPCI Wom­
en Committee will support women and bring 
more highly motivated FOs into catheteriza­
tion laboratories.
study limitations Factors affecting sex parity 
in cardiology are complex and diverse, but they 
did not represent the subject of our research. 
Nevertheless, they may significantly influence 
the current practice pattern in the field of IC. 
Statistical significance strongly depends on the 
study sample size. Due to large sample sizes, we 
observed statistical significance even in terms 
of small treatment effects (eg, differences in 
the mean amount of the contrast agent dose of 
1.39 ml for angiography and 3.12 ml for PCI be­
tween operators), which may remain clinically 
irrelevant. Finally, ORPKI records are limited 
to clinical and procedural data without further 
hospital and long ­term follow ­up.
conclusions Data from the ORPKI registry 
provide a contemporary view of the current IC 
practice in Poland. Women represent a minority 
of operators in IC and are responsible for a small 
percentage of PCIs. The practice patterns of PCI 
performed by female interventionalists are simi­
lar to those of MOs and comply with the Europe­
an Society of Cardiology guidelines on myocar­
dial revascularization. Future multicenter anal­
ysis is needed to further investigate the impact 
of the operator’s sex on clinical outcomes in IC.
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